Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.
Research Center for Applied Sciences, Academia Sinica, Taipei 11529, Taiwan.
Proc Natl Acad Sci U S A. 2023 Jan 31;120(5):e2207091120. doi: 10.1073/pnas.2207091120. Epub 2023 Jan 23.
Galectin-4, a member of the galectin family of animal glycan-binding proteins (GBPs), is specifically expressed in gastrointestinal epithelial cells and is known to be able to bind microbes. However, its function in host-gut microbe interactions remains unknown. Here, we show that intracellular galectin-4 in intestinal epithelial cells (IECs) coats cytosolic serovar Worthington and induces the formation of bacterial chains and aggregates. Galectin-4 enchains bacteria during their growth by binding to the O-antigen of lipopolysaccharides. Furthermore, the binding of galectin-4 to bacterial surfaces restricts intracellular bacterial motility. Galectin-4 enhances caspase-1 activation and mature IL-18 production in infected IECs especially when autophagy is inhibited. Finally, orally administered serovar Worthington, which is recognized by human galectin-4 but not mouse galectin-4, translocated from the intestines to mesenteric lymph nodes less effectively in human galectin-4-transgenic mice than in littermate controls. Our results suggest that galectin-4 plays an important role in host-gut microbe interactions and prevents the dissemination of pathogens. The results of the study revealed a novel mechanism of host-microbe interactions that involves the direct binding of cytosolic lectins to glycans on intracellular microbes.
半乳糖凝集素-4(Galectin-4)是动物糖结合蛋白(GBP)家族的成员,特异性表达于胃肠道上皮细胞,已知其能够与微生物结合。然而,其在宿主-肠道微生物相互作用中的功能仍不清楚。在这里,我们发现肠道上皮细胞(IEC)内的细胞内半乳糖凝集素-4可包裹血清型沃辛顿菌(serovar Worthington),并诱导细菌链和聚集体的形成。半乳糖凝集素-4通过与脂多糖的 O-抗原结合,在细菌生长过程中使细菌连锁化。此外,半乳糖凝集素-4与细菌表面的结合限制了细菌的胞内运动。半乳糖凝集素-4增强了感染的 IEC 中 caspase-1 的激活和成熟的 IL-18 产生,尤其是在自噬被抑制时。最后,口服给药可被人源半乳糖凝集素-4识别但不能被鼠源半乳糖凝集素-4识别的血清型沃辛顿菌,在人源半乳糖凝集素-4转基因小鼠中向肠系膜淋巴结的转移效率低于同窝对照小鼠。我们的结果表明,半乳糖凝集素-4在宿主-肠道微生物相互作用中发挥着重要作用,可防止病原体的传播。该研究结果揭示了一种宿主-微生物相互作用的新机制,涉及细胞质凝集素与细胞内微生物糖链的直接结合。